Process for the electronic submission of medicinal product information - Chapter 3
Submitted by Anonymous (not verified) on 12 August 2026 - 9:03
Process for the electronic submission of medicinal product information - Chapter 3
Product Management Services (PMS) - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in Europe - Chapter 2 - tracked changes
Submitted by Anonymous (not verified) on 12 August 2026 - 8:50
Product Management Services (PMS) - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in Europe - Chapter 2 - tracked changes
Product Management Services (PMS) - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in Europe - Chapter 2
Submitted by Anonymous (not verified) on 12 August 2026 - 8:40
Product Management Services (PMS) - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in Europe - Chapter 2
Shared Decision-Making – Optimizing Decisions Through Clinical Expertise and Patient Preferences
Submitted by Aneta on 11 August 2026 - 15:39
The EFIM Early Career Group is pleased to invite you to an upcoming webinar exploring the role of shared decision-making in modern Internal Medicine.
Date: 10 September 2026
Time: 16:30 CET
Fees for veterinary medicines
Submitted by Anonymous (not verified) on 11 August 2026 - 14:50
Fees for veterinary medicines
Human medicines European public assessment report (EPAR): Zebinix, eslicarbazepine acetate, Date of authorisation: 21/04/2009, Revision: 34, Status: Authorised
Submitted by Anonymous (not verified) on 11 August 2026 - 13:24
Human medicines European public assessment report (EPAR): Zebinix, eslicarbazepine acetate, Date of authorisation: 21/04/2009, Revision: 34, Status: Authorised
Human medicines European public assessment report (EPAR): Tecfidera, dimethyl fumarate, Date of authorisation: 30/01/2014, Revision: 33, Status: Authorised
Submitted by Anonymous (not verified) on 11 August 2026 - 13:00
Human medicines European public assessment report (EPAR): Tecfidera, dimethyl fumarate, Date of authorisation: 30/01/2014, Revision: 33, Status: Authorised
Fees for human medicines
Submitted by Anonymous (not verified) on 11 August 2026 - 10:43
Fees for human medicines
Human medicines European public assessment report (EPAR): Usgena, ustekinumab, Date of authorisation: 17/11/2025, Revision: 2, Status: Authorised
Submitted by Anonymous (not verified) on 11 August 2026 - 9:54
Human medicines European public assessment report (EPAR): Usgena, ustekinumab, Date of authorisation: 17/11/2025, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Kanjinti, trastuzumab, Date of authorisation: 16/05/2018, Revision: 12, Status: Authorised
Submitted by Anonymous (not verified) on 11 August 2026 - 9:19
Human medicines European public assessment report (EPAR): Kanjinti, trastuzumab, Date of authorisation: 16/05/2018, Revision: 12, Status: Authorised